SkinBioTherapeutics PLC

NEW
LSE:SBTX (UK)  
£ 0.12 -0.0025 (-2.13%) Jul 31
At Loss
P/B:
3.79
Market Cap:
£ 29.80M ($ 40.12M)
Enterprise V:
£ 27.62M ($ 37.18M)
Volume:
140.38K
Avg Vol (2M):
841.79K
Trade In:
Volume:
140.38K
At Loss
Avg Vol (2M):
841.79K

SkinBioTherapeutics PLC (LSE:SBTX) Dividend

SkinBioTherapeutics PLC (LSE:SBTX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -18.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LSE:SBTX Dividend

Does SkinBioTherapeutics PLC (LSE:SBTX) pay a dividend?

SkinBioTherapeutics PLC (LSE:SBTX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't SkinBioTherapeutics PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. SkinBioTherapeutics PLC has returned capital to shareholders via buybacks at a rate of -18.2% over the past 3 years.

What are dividend-paying alternatives to SkinBioTherapeutics PLC?

For dividend-paying alternatives in SkinBioTherapeutics PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.